1. Different Induction Response Criteria Do Not Influence 1‐Year Response and Remission Rates of Ustekinumab 90 Mg Q8w in Phase III Program: 665. (October 2016) Authors: Naessens, Dominik; Johanns, Jewel; Gasink, Chris Journal: American journal of gastroenterology Issue: Volume 111(2016)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Early Improvement After Intravenous Ustekinumab Induction in Patients With Ulcerative Colitis: Results From the UNIFI Induction Trial: 689. (October 2019) Authors: Sands, Bruce E.; Abreu, Maria T.; Marano, Colleen; Baker, Thomas; O'Brien, Christopher; Zhang, Hongyan; Johanns, Jewel; Rowbotham, David; Leong, Rupert W. L.; Danese, Silvio Journal: American journal of gastroenterology Issue: Volume 114 (2019)ACG Abstracts 1:Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and Safety of Dose Adjustment and Delayed Response to Ustekinumab in Moderate ‐ Severe Crohn's Disease Patients: Results from the IM‐UNITI Maintenance Study: 2016 ACG Presidential Poster Award: 663. (October 2016) Authors: Sands, Bruce; Gasink, Chris; Jacobstein, Doug; Gao, Long Long; Johanns, Jewel; Szapary, Philippe; Colombel, Jean‐Frederic; Targan, Stephan; Ghosh, Subrata; Sandborn, William J. Journal: American journal of gastroenterology Issue: Volume 111(2016)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Endoscopic Healing in Induction and Maintenance with Ustekinumab in the Phase 3 UNITI Crohn's Disease Program: 2016 ACG Presidential Poster Award: 605. (October 2016) Authors: Sandborn, William J.; Gasink, Chris; Chan, Daphne; Lang, Yinghua; Pollack, Paul; Hanauer, Stephen; Wolf, Douglas; Jacobstein, Doug; Johanns, Jewel; Szapary, Philippe; Feagan, Brian; Rutgeerts, Paul Journal: American journal of gastroenterology Issue: Volume 111(2016)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Exposure‐Response to SC Ustekinumab In Moderate‐Severe Crohn's Disease: Results From the IM‐UNITI Maintenance Study: 660. (October 2017) Authors: Adedokun, Omoniyi J.; Xu, Zhenhua; Gasink, Christopher; Jacobstein, Douglas; Szapary, Philippe; Johanns, Jewel; Gao, Long Long; Davis, Hugh M.; Hanauer, Stephen; Feagan, Brian G.; Ghosh, Subrata; Sandborn, William J. Journal: American journal of gastroenterology Issue: Volume 112(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Fecal Lactoferrin (fLac) and Calprotectin (fCal) as Surrogate Markers of Mucosal Healing: Post‐hoc Analysis from the PURSUIT SC Induction Study: 1864. (October 2015) Authors: Reinisch, Walter; Sandborn, William J.; Feagan, Brian; Rutgeerts, Paul; Gibson, Peter; Collins, Judith; Tarabar, Dino; Hebzda, Zbigniew; Colombel, Jean‐Frederic; Marano, Colleen W.; Strauss, Richard S.; Johanns, Jewel; Zhang, Hongyan Journal: American journal of gastroenterology Issue: Volume 110(2015)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial. (April 2023) Authors: Feagan, Brian G; Sands, Bruce E; Sandborn, William J; Germinaro, Matthew; Vetter, Marion; Shao, Jie; Sheng, Shihong; Johanns, Jewel; Panés, Julián; Tkachev, Alexander; Kalimullina, Dilara; Petryka, Robert; Osipenko, Marina; Tsarynna, Nataliia; Bilianskyi, Leonid; Kleczkowski, Dariusz; Yurkiv, And... Journal: Lancet gastroenterology and hepatology Issue: Volume 8:Number 4(2023) Page Start: 307 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. IM-UNITI: Three-year Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease. (3rd June 2019) Authors: Hanauer, Stephen B; Sandborn, William J; Feagan, Brian G; Gasink, Christopher; Jacobstein, Douglas; Zou, Bin; Johanns, Jewel; Adedokun, Omoniyi J; Sands, Bruce E; Rutgeerts, Paul; de Villiers, Willem J S; Colombel, Jean-Frédéric; Ghosh, Subrata Journal: Journal of Crohn's and colitis Issue: Volume 14:Number 1(2020) Page Start: 23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Impact of Response and Inflammatory Burden at Start of Maintenance Therapy on Clinical Efficacy of Ustekinumab Dosing Regimen in UC: Week 44 Results From UNIFI: 842. (October 2019) Authors: Panaccione, Remo; Peyrin‐Biroulet, Laurent; Danese, Silvio; Marano, Colleen; O'Brien, Christopher D.; Szapary, Philippe; Zhang, Hongyan; Johanns, Jewel; Leong, Rupert W L; Arasaradnam, Ramesh P.; Rowbotham, David; Abreu, Maria T.; Sands, Bruce E. Journal: American journal of gastroenterology Issue: Volume 114 (2019)ACG Abstracts 1:Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Maintenance of Efficacy and Continuing Safety of Golimumab for Active Ulcerative Colitis: PURSUIT‐SC Maintenance Study Extension Through 1 Year. Issue 4 (April 2016) Authors: Gibson, Peter R; Feagan, Brian G; Sandborn, William J; Marano, Colleen; Strauss, Richard; Johanns, Jewel; Padgett, Lakshmi; Collins, Judith; Tarabar, Dino; Hebzda, Zbigniew; Rutgeerts, Paul; Reinisch, Walter Journal: Clinical and translational gastroenterology Issue: Volume 7:Issue 4(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗